An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective

MEH Kayesh, H Nazneen, M Kohara… - Frontiers in …, 2024 - frontiersin.org
Dengue is an important vector-borne disease occurring globally. Dengue virus (DENV)
infection can result in a potentially life-threatening disease. To date, no DENV-specific …

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

I LeFevre, L Bravo, N Folschweiller, EL Medina… - npj Vaccines, 2023 - nature.com
Immunobridging is an important methodology that can be used to extrapolate vaccine
efficacy estimates to populations not evaluated in clinical studies, and that has been …

[PDF][PDF] IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial

JG Low, HM Oh, YS Leo, S Kalimuddin… - The American Journal …, 2024 - researchgate.net
The profiles of vaccine-induced dengue antibodies may differ from those produced following
natural infection and could potentially interfere with the interpretation of diagnostic tests. We …

[PDF][PDF] Studies on development of novel therapeutic agent against RNA virus infection

登治謙 - 2023 - eprints.lib.hokudai.ac.jp
DENV is a positive-sense single-stranded RNA virus belonging to the Flaviviridae family and
the genus Flavivirus and has four known serotypes. The genus Flavivirus also includes West …